Related Experiment Video
Updated: Feb 8, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery
Narsireddy Amreddy1, Anish Babu1, Ranganayaki Muralidharan1
1The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Abstract:
Effective and safe delivery of anticancer agents is among the major challenges in cancer therapy. The majority of anticancer agents are toxic to normal cells, have poor bioavailability, and lack in vivo stability. Recent advancements in nanotechnology provide safe and efficient drug delivery systems for successful delivery of anticancer agents via nanoparticles. The physicochemical and functional properties of the nanoparticle vary for each of these anticancer agents, including chemotherapeutics, nucleic acid-based therapeutics, small molecule inhibitors, and photodynamic agents. The characteristics of the anticancer agents influence the design and development of nanoparticle carriers. This review focuses on strategies of nanoparticle-based drug delivery for various anticancer agents. Recent advancements in the field are also highlighted, with suitable examples from our own research efforts and from the literature.
Insights
Nanotechnology offers safe and effective nanoparticle drug delivery systems for cancer therapy, overcoming issues like toxicity and poor bioavailability of traditional anticancer agents. This review explores nanoparticle strategies for various cancer therapeutics.
Area of Science:
- Oncology
- Materials Science
- Nanotechnology
Background:
- Effective anticancer agent delivery faces challenges including toxicity to normal cells, poor bioavailability, and instability in vivo.
- Nanotechnology presents a promising solution with nanoparticles as safe and efficient drug delivery systems.
- Various anticancer agents, such as chemotherapeutics and nucleic acid-based therapeutics, require tailored nanoparticle designs.
Purpose of the Study:
- To review nanoparticle-based drug delivery strategies for diverse anticancer agents.
- To highlight recent advancements in nanoparticle drug delivery for cancer therapy.
- To discuss how the properties of anticancer agents influence nanoparticle carrier development.
Main Methods:
- Review of scientific literature on nanoparticle drug delivery systems in cancer therapy.
- Analysis of physicochemical and functional properties of nanoparticles for different therapeutic agents.
- Inclusion of examples from published research and the authors' own work.
Main Results:
- Nanoparticles can be engineered to improve the delivery, efficacy, and safety of various anticancer agents.
- The design of nanoparticle carriers is critically dependent on the specific characteristics of the anticancer agent being delivered.
- Recent advancements show significant progress in tailoring nanoparticles for targeted cancer treatment.
Conclusions:
- Nanoparticle-based drug delivery is a key strategy for overcoming limitations in current cancer therapy.
- Tailored nanoparticle design is essential for optimizing the delivery of different classes of anticancer agents.
- Continued research in nanotechnology holds significant promise for advancing cancer treatment efficacy and safety.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

